- Home
- EXEL vs HTHT Comparison
EXEL vs HTHT Comparison
Compare EXEL & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- HTHT
- Stock Information
- Founded
- EXEL 1994
- HTHT 2005
- Country
- EXEL United States
- HTHT China
- Employees
- EXEL N/A
- HTHT N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- HTHT Hotels/Resorts
- Sector
- EXEL Health Care
- HTHT Consumer Discretionary
- Exchange
- EXEL Nasdaq
- HTHT Nasdaq
- Market Cap
- EXEL 9.7B
- HTHT 11.6B
- IPO Year
- EXEL 2000
- HTHT 2010
- Fundamental
- Price
- EXEL $34.45
- HTHT $35.81
- Analyst Decision
- EXEL Buy
- HTHT Strong Buy
- Analyst Count
- EXEL 18
- HTHT 4
- Target Price
- EXEL $31.72
- HTHT $48.00
- AVG Volume (30 Days)
- EXEL 2.6M
- HTHT 1.6M
- Earning Date
- EXEL 10-29-2024
- HTHT 11-26-2024
- Dividend Yield
- EXEL N/A
- HTHT 4.36%
- EPS Growth
- EXEL 441.02
- HTHT 219.13
- EPS
- EXEL 1.55
- HTHT 1.62
- Revenue
- EXEL $2,081,598,000.00
- HTHT $3,206,043,837.00
- Revenue This Year
- EXEL $20.53
- HTHT $11.11
- Revenue Next Year
- EXEL $1.54
- HTHT $8.36
- P/E Ratio
- EXEL $22.26
- HTHT $22.06
- Revenue Growth
- EXEL 17.31
- HTHT 30.82
- 52 Week Low
- EXEL $19.20
- HTHT $27.03
- 52 Week High
- EXEL $36.60
- HTHT $42.98
- Technical
- Relative Strength Index (RSI)
- EXEL 67.10
- HTHT 44.66
- Support Level
- EXEL $27.86
- HTHT $35.20
- Resistance Level
- EXEL $36.49
- HTHT $38.88
- Average True Range (ATR)
- EXEL 0.98
- HTHT 0.97
- MACD
- EXEL -0.01
- HTHT -0.36
- Stochastic Oscillator
- EXEL 74.10
- HTHT 14.70
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About HTHT H World Group Limited
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, manachised, and franchised models. The company has two operating segments; legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.